113 related articles for article (PubMed ID: 19995395)
21. Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia.
Hubmann R; Schwarzmeier JD; Shehata M; Hilgarth M; Duechler M; Dettke M; Berger R
Blood; 2002 May; 99(10):3742-7. PubMed ID: 11986231
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation.
Tonetti DA; Horio M; Collart FR; Huberman E
Cell Growth Differ; 1992 Oct; 3(10):739-45. PubMed ID: 1445803
[TBL] [Abstract][Full Text] [Related]
23. Elucidating the role of protein kinase C in chronic lymphocytic leukaemia.
Michie AM; Nakagawa R
Hematol Oncol; 2006 Sep; 24(3):134-8. PubMed ID: 16841369
[TBL] [Abstract][Full Text] [Related]
24. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC.
Perez-Chacon G; Vargas JA; Jorda J; Morado M; Rosado S; Martin-Donaire T; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
Leuk Res; 2007 Feb; 31(2):183-93. PubMed ID: 16725198
[TBL] [Abstract][Full Text] [Related]
25. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
26. Post-transcriptional silencing of Notch2 mRNA in chronic lymphocytic [corrected] leukemic cells of B-CLL patients.
Fatima K; Paracha RZ; Qadri I
Mol Biol Rep; 2012 May; 39(5):5059-67. PubMed ID: 22161246
[TBL] [Abstract][Full Text] [Related]
27. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori activates protein kinase C delta to control Raf in MAP kinase signalling: role in AGS epithelial cell scattering and elongation.
Brandt S; Wessler S; Hartig R; Backert S
Cell Motil Cytoskeleton; 2009 Oct; 66(10):874-92. PubMed ID: 19437514
[TBL] [Abstract][Full Text] [Related]
29. The ATR-p53 pathway is suppressed in noncycling normal and malignant lymphocytes.
Jones GG; Reaper PM; Pettitt AR; Sherrington PD
Oncogene; 2004 Mar; 23(10):1911-21. PubMed ID: 14755251
[TBL] [Abstract][Full Text] [Related]
30. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
31. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL.
Barna G; Reiniger L; Tátrai P; Kopper L; Matolcsy A
Hematol Oncol; 2008 Sep; 26(3):167-70. PubMed ID: 18381689
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
33. The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia.
Fournier S; Yang LP; Delespesse G; Rubio M; Biron G; Sarfati M
Br J Haematol; 1995 Feb; 89(2):373-9. PubMed ID: 7873388
[TBL] [Abstract][Full Text] [Related]
34. Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia.
Rees-Unwin KS; Faragher R; Unwin RD; Adams J; Brown PJ; Buckle AM; Pettitt A; Hutchinson CV; Johnson SM; Pulford K; Banham AH; Whetton AD; Lucas G; Mason DY; Burthem J
Br J Haematol; 2010 Feb; 148(4):534-43. PubMed ID: 19961478
[TBL] [Abstract][Full Text] [Related]
35. CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes.
Bund D; Mayr C; Kofler DM; Hallek M; Wendtner CM
Exp Hematol; 2007 Jun; 35(6):920-30. PubMed ID: 17533046
[TBL] [Abstract][Full Text] [Related]
36. Pathways controlling the expression of surface CD21 (CR2) and CD23 (Fc(epsilon)IIR) proteins in human malignant B cells.
Shubinsky G; Schlesinger M; Polliack A; Rabinowitz R
Leuk Lymphoma; 1997 May; 25(5-6):521-30. PubMed ID: 9250823
[TBL] [Abstract][Full Text] [Related]
37. Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia.
Schwarzmeier JD; Hubmann R; Düchler M; Jäger U; Shehata M
Leuk Lymphoma; 2005 Feb; 46(2):157-65. PubMed ID: 15621797
[TBL] [Abstract][Full Text] [Related]
38. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation.
De Falco F; Del Papa B; Baldoni S; Sabatini R; Falzetti F; Di Ianni M; Martelli MP; Mezzasoma F; Pelullo M; Marconi P; Sportoletti P; Screpanti I; Rosati E
Cell Death Dis; 2018 Nov; 9(12):1160. PubMed ID: 30478302
[TBL] [Abstract][Full Text] [Related]
39. Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL.
De Falco F; Sabatini R; Del Papa B; Falzetti F; Di Ianni M; Sportoletti P; Baldoni S; Screpanti I; Marconi P; Rosati E
Oncotarget; 2015 Jun; 6(18):16559-72. PubMed ID: 26041884
[TBL] [Abstract][Full Text] [Related]
40. Identification of new phosphorylation sites of CD23 in B-cells of patients with chronic lymphocytic leukemia.
Maďarová M; Mucha R; Hresko S; Makarová Z; Gdovinová Z; Szilasiová J; Vitková M; Guman T; Štecová N; Dobransky T
Leuk Res; 2018 Jul; 70():25-33. PubMed ID: 29763855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
